Previous Article | Next Article ![]()
Infection and Immunity, November 2002, p. 6121-6128, Vol. 70, No. 11
0019-9567/02/$04.00+0 DOI: 10.1128/IAI.70.11.6121-6128.2002
Copyright © 2002, American Society for Microbiology. All Rights Reserved.
Antoine de Saizieu,1,
Hans-Joachim Schönfeld,1 Markus Kamber,1,
Roland Lange,1,|| Charles J. Thompson,2 and Malcolm G. Page1*
F. Hoffmann-La Roche Ltd., 4070 Basel,1 Division of Microbiology, Biozentrum, University of Basel, 4056 Basel, Switzerland2
Received 15 January 2002/ Returned for modification 21 March 2002/ Accepted 29 May 2002
|
|
|---|
|
|
|---|
73) of C. crescentus (42). Two-component systems have been recently identified in Streptococcus pneumoniae, a major cause of community-acquired pneumonia (3). One of the best-studied two-component systems in S. pneumoniae is comDE, which is a key regulator of natural competence (9, 33). This system belongs to the quorum-sensing family of two-component systems. A small heptadecapeptide coexpressed with comD-comE was proposed to be the signaling molecule (20, 33). A second TCRS, ciaRH, is also involved in regulating competence of S. pneumoniae (18). Recently, the predicted response regulator genes of 13 TCRS found in the nearly complete S. pneumoniae genome sequence were disrupted (26, 42). No viable response regulator knockout mutants could be obtained for the vic system. The only other essential TCRS known so far was implicated in cell cycle control (24).
In this work, we describe the transcriptional organization of the vic operon and its high degree of conservation among gram-positive bacteria. We also demonstrate that VicR functions as a phospho-acceptor protein and that VicK can be autophosphorylated in vitro. vic operon mutants were constructed and systematically analyzed for effects on growth, competence, and virulence.
|
|
|---|
|
View this table: [in a new window] |
TABLE 1. Plasmids and strains used in this study
|
![]() View larger version (55K): [in a new window] |
FIG. 1. Genetic organization in different S. pneumoniae mutant strains used for studying the vic operon. Strains whose designations end with the suffix "KO" are null mutants, while that ending in the suffix "KOP" is a null mutant in which the downstream gene is transcribed by a synthetic promoter. Strains whose designations begin with the prefix "SOB" are S. pneumoniae overexpressing strains. The erythromycin resistance (Eryr) cassette of pJDC9, the synthetic promoter, is described in Materials and Methods and is represented by an arrow on top of a vertical bar. Consensus ribosomal binding sites (RBS) (see Materials and Methods) are also shown. Genes followed or preceded by a vertical zigzag line end or start with an in-frame stop codon, respectively. The strong transcriptional terminators of pJDC9 are represented by an open circle on top of a vertical bar.
|
Computational analysis and sequence data. Genetics Computer Group (Madison, Wis.) programs (version 9.1) were routinely used for sequence comparison. Transmembrane domains were predicted using TMpred software (http://www.isrec.isb-sib.ch/software/TMPRED_form.html) (24) and ALOM software (25). The program SMART (http://smart.embl-heidelberg.de) (39) was used to detect the PAS in S. pneumoniae VicK, the prediction of which was verified by detailed comparison at the sequence level. (PAS is the acryonym formed from the names of the proteins in which the domains were first recognized: Drosophila period clock protein [PER], the vertebrate aryl hydrocarbon receptor nuclear translocator [ARNT], and Drosophila single-minded protein [SIM].) The Streptococcus pyogenes genome sequence was obtained from the University of Oklahoma Advanced Center for Genome Technology (http://www.genome.ou.edu/strep.html). The S. pneumoniae sequence information was obtained as described previously (26). Genomic sequence databases for Staphylococcus aureus and Enterococcus faecalis were obtained through Human Genome Sciences, Inc. (Rockville, Md.). Both databases cover about 98% of the genome. Ambiguous sequences of interest were resequenced.
Promoter mapping and detection of operon transcripts. RNA extraction and Northern blot analysis were carried out as described previously (11). The Promega (Madison, Wis.) primer extension system was used for promoter mapping. A dideoxy cycle sequencing reaction (SequiTherm Cycle sequencing; Epicentre Technologies, Madison, Wis.) was used as a sizing standard.
Expression and purification of VicR. The vicR gene was cloned into a pDS56 RBSII six-His] derivative (39). First, the NdeI site of this vector (at position 1378) was eliminated by cutting with NdeI, filling in the recessed 3' ends, and recircularization. This plasmid was cut with BamHI and HindIII, and a polylinker with sites for ClaI, NdeI, SalI, BamHI, and HindIII was introduced. A coding region with the start codon in the NdeI site (CATATG) introduced in this vector results in an IPTG (isopropyl-ß-D-thiogalactopyranoside)-inducible gene, encoding a protein with an amino-terminal tail consisting of six histidines (39). The sequence between the Shine-Dalgarno sequence (AGGAG) and the stop codon (TAG) is AGGAG AAATTAACT ATG AGA GGA TCT CAT CAC CAT CAC CAT CAC GGG ATC GAT CAT ATG GTC GAC GGA TCC AAG CTT AAT TAG. The vector (pDSNde) was then obtained by cutting pDSNdeHis with EcoRI and BamHI and recircularizing using the linkers S/D-1 (AAT TAA AGG AGG GTT TCA TAT GAA TTC G) and S/D-2 (GAT CCG AAT TCA TAT GAA ACC CTC CTT T).
A gene with the start codon in the NdeI site (CATATG) can be expressed with no amino-terminal extension. VicR was cloned into pDSNde between NdeI and BamHI restriction sites, leading to pNR2, and overexpressed in E. coli M15[pREP4] (Qiagen) using standard procedures. About 100 mg of VicR was obtained from a 2-liter culture. Details of VicR purification and refolding will be described elsewhere. Briefly, E. coli cells were lysed by pressure treatment with a homogenizer (model MINI-Lab; Rannie, Denmark) and the recombinant protein was precipitated with 0.6% (wt/vol) polyethylenimine. After extraction of the precipitate with 1 M NaCl, VicR was precipitated again by reducing the salt concentration and then resolubilized under denaturing conditions (6 M urea). Some protein contaminants were removed by anion-exchange chromatography (Q-Sepharose) in the presence of 6 M urea at a salt concentration (100 mM NaCl, 10 mM MgCl2) at which VicR did not bind to the column. VicR was refolded by binding it to the same ion-exchange column at a lower salt concentration, washing with buffer (from which urea was omitted), and elution with a salt gradient. Fractions found to be homogeneous by sodium dodecyl sulfate (SDS)-polyacrylamide gel electrophoresis and by quasi-elastic light scattering analysis (37) were pooled and further purified by gel filtration chromatography in the presence of 1 M NaCl. Homogeneous fractions obtained from the sizing column were pooled, adjusted to 1.5 mg of protein/ml, dialyzed against 50 mM Tris-HCl (pH 8.0)-500 mM NaCl-10 mM MgCl2, and filtered (pore size, 0.2 µm). The authenticity of the purified VicR protein was verified by mass spectroscopy, N-terminal sequencing, and amino acid analysis. Aliquots were stored at -80°C.
Expression and preparation of VicK in membrane vesicles. The vicK gene was also cloned into pDSNde, leading to pvicK, and overexpressed in E. coli M15[pREP4] (Qiagen) using standard procedures. Pellets from 1-liter expression cultures were resuspended in 20 ml of a solution containing 100 mM HEPES (pH 8), 10% glycerol, 1 mM MgSO4, 150 mM NaCl, and Benzonase (250 U/µl; Boehringer Mannheim) and sonicated in a water bath for 18 min while cooling the sample to 4°C every 3 min. The sonicated sample was centrifuged for 20 min at 3,000 x g and 4°C. The supernatant of this centrifugation was subjected to ultracentrifugation at 150,000 x g and 4°C for 1 h. The pellet was resuspended in 100 µl of 50 mM Tris-HCl (pH 7.5)-50 mM KCl-5 mM MgCl2-1 mM dithiothreitol (DTT), yielding a protein concentration of about 18 mg/ml.
Phosphorylation assays.
Fusion proteins of maltose binding protein (MBP) and the cytoplasmic domain of VanS (MBP-VanS) and of MBP and VanR (MBP-VanR) were expressed and purified using the pMAL protein fusion and purification system (New England Biolabs, Inc., Beverly, Mass.), but no EDTA was added to the elution buffer. The constructs for MBP-VanS and MBP-VanR were kindly provided by C. Walsh (41). MBP-VanS (180 µg) was added to 9.25 GBq of [
-32P]ATP and 0.5 mM ATP in a reaction buffer containing 50 mM HEPES (pH 7.4), 50 mM KCl, and 50 mM MgCl2. The mixture was incubated at 25°C for 1 h. Then the autophosphorylated protein was separated from ATP on a 1-ml Sephadex G-50 spin column (Pharmacia). Phosphotransfer from histidine kinase to response regulator was performed in the same reaction buffer at room temperature for 5 min. The reaction was stopped by adding concentrated gel loading buffer containing the following (final concentration): 10 mM DTT, 2% SDS, 10 mM Tris-HCl (pH 6.8), 12.5% glycerol, 2.5 mM Na2HPO4, 5 mM EDTA, and 0.05% bromophenol blue. Samples were then subjected to SDS-polyacrylamide gel electrophoresis using 10-to-20% gradient gels at 120 V.
VicK autophosphorylation assays were performed in a buffer containing 50 mM Tris-HCl (pH 7.5), 50 mM KCl, 5 mM MgCl2, 1 mM DTT, 0.33 mM NADH, 2.5 mM phosphoenolpyruvate, 1 mM ATP, 0.165 U of pyruvate kinase, 0.25 U of lactate dehydrogenase (from rabbit muscle; Sigma), 555 kBq of [
-32P]ATP, 3.8 mM para-nitrophenyl phosphate, 0.5 mM o-phospho-L-threonine, 5 mM o-phospho-L-serine, 50 mM sodium orthovanadate, and 80 µg of VicK membrane preparation. After incubation at 30°C for 7 min, the reaction was stopped by the addition of SDS loading buffer comprised of (final concentration) 50 mM DTT, 4% SDS, 50 mM Tris-HCl (pH 6.8), 12.5% glycerol, 2.5 mM NaH2PO4, 0.05% bromophenol blue, and 5 mM EDTA. The 10-to-20% gel was run at 120 V and blotted on a polyvinylidene difluoride membrane in a semidry transfer apparatus (Hoefer). Autoradiography was carried out using Kodak Biomax MS films.
Gene disruption and overexpression in S. pneumoniae. vicK and vicX gene disruptions in pneumococcal strains R6, sp1, and sp1711 (Table 1) were obtained by transformation using pAS1-based plasmids (29) pKOHK2 (vicK) and pKOOX2 (vicX). Correct integration of the constructs was checked by PCR. A synthetic promoter, called B2, designed for overexpression in S. pneumoniae: ctc gag TCA GAA AAT TAT TTT AAA TTT CCT CTT GAC ATT TTT GGT TTT TTA TGA TAT AAT AGT TTT AAG tct aga att c (restriction sites [XhoI, XbaI, EcoRI] are underlined, and the vicR-specific sequence is shown in lowercase type) was based on the rRNA binding protein 1 promoter from Bacillus subtilis (nucleotides 7 to 31), -35 and "extended -10" consensus boxes (nucleotides 32 to 37 and nucleotides 50 to 61) (27), the sequence from the spacing region of the 5'-phosphoribosyl-5-aminoimidazole-4-N-succinocarboxamide synthetase from S. pneumoniae (purC) (nucleotides 38 to 49), and the repA promoter sequence (from the -10 box to the initiator site) (nucleotides 62 to 69) (10). The promoter was cloned into pAS1 (XhoI/EcoRI), leading to pASPB2. This new vector was used to convert pASPB2 into an integrative S. pneumoniae expression vector by adding a synthetic ribosome binding site as an extension to the 3' primer used in PCR amplification of the insert, described below. For expression of the complete vic operon, a PCR product of 522 bp was synthesized from primers AP-97 and AP-98. AP-97 is GAC GAA TTC AAA GGA GGG TTT CAT atg aaa aaa ata cta att gta g, where restriction sites (EcoRI and NdeI) are underlined, the ribosome binding site is shown in boldface type, and the vicR-specific sequence is shown in lowercase type. AP-98 is AAA GGG ATC CTA acg atg ggt taa gtc tag ttc (nomenclature is the same as that for AP-97). This PCR fragment was cloned into pASPB2 using EcoRI/BamHI, leading to pOBRR2. Subsequent cloning of PCR fragments of 416 and 493 bp extending from the start codon of vicK and vicX into NdeI/BamHI restriction sites of pOBRR2 led to pOBHK2 and pOBOX2, respectively. After transformation and integration into the S. pneumoniae genome, the respective plasmids produced strains SOBvicR, SOBvicK, and SOBvicX, overexpressing the complete vic operon, vicK and vicX, or only vicX, respectively. A vicK gene disruption which also introduced a B2 downstream promoter was obtained by cloning a 5' EcoRI/BamHI fragment of vicK into pASPB2, leading to pHK2KOP (after S. pneumoniae transformation to strain vicKKOP).
Competence in mutant strains. S. pneumoniae was transformed essentially according to the method of Apfel et al. (4). When transforming mutant strains with the replicative plasmid pGK13-KAN (Table 1), erythromycin selection was maintained during the entire procedure. The number of colonies resistant to both erythromycin and kanamycin was compared to the number of kanamycin-resistant colonies obtained in a control transformation in S. pneumoniae R6.
Experimental virulence. Null and overexpressing vic operon mutants were also constructed in two different virulent strains of S. pneumoniae (Sp1 and Sp1711 [Table 1]). Control and mutant strains were grown in Todd-Hewitt medium as indicated above, but with erythromycin (250 ng/ml) plus 5% fetal calf serum (Life Technologies, Rockville, Md.). During exponential growth phase, 2 ml of bacterial culture was harvested and diluted with phosphate-buffered saline to a calculated dose of 4 x 106 CFU (Sp1) and 103 CFU (Sp1711). Aliquots of the suspensions of each mutant strain were each injected intraperitoneally into five female mice (C57BL6/J [18 to 20 g]; Bethesda Research Laboratories). Mean survival time was calculated as the time from injection of bacteria until death of the infected mouse or as 15 days for survivors. Attenuation in virulence was recorded as an increase in mean survival time. These studies were performed in full compliance with local Swiss regulations for animal experimentation.
Nucleotide sequence accession numbers. The sequences of the following vic operon genes have been submitted to the EMBL nucleotide sequence database under the indicated accession numbers: S. pneumoniae vicR and vicK, AJ06392; S. pneumoniae vicX, AJ012049; E. faecalis vic operon and flanking genes, AJ012050; S. pyogenes vic operon and flanking genes, AJ012051; S. aureus vic operon and flanking genes, AJ012052.
|
|
|---|
![]() View larger version (38K): [in a new window] |
FIG. 2. Gene organization in the vic operon. Direction of transcription and translation for the three genes in the three open reading frames is indicated by arrows. The putative terminator is indicated by an open circle on top of a vertical bar. The -10 and -35 boxes are indicated. They were identified by primer extension experiments. The organization of four vic operon homologuesthose of S. pyogenes, B. subtilis, S. aureus, and E. faecalisis shown at bottom. Identical shading was used for homologous genes.
|
|
View this table: [in a new window] |
TABLE 2. Alignment of part of the VicX sequence with its closest homologuesa
|
![]() View larger version (54K): [in a new window] |
FIG. 3. Transcriptional organization of the vic operon. (A) Autoradiography of a primer extension experiment. Dideoxy DNA sequence analysis (lanes T, G, C, and A) and primer extension reactions (lane 1 with 30 µg S. pneumoniae RNA and lane 2 without added RNA) were performed using a specific primer for the 5' end of the vicR gene. RNA was isolated from exponentially growing S. pneumoniae R6 cells. Only one band was observed, as indicated by the arrow. (B) Autoradiography of a Northern blot hybridization experiment. RNA was isolated from S. pneumoniae R6 and SOBvicR cells. The probe used in the hybridization covered the complete vicR gene and was labeled with [ -32P]CTP by in vitro transcription with the Lig'nscribe kit (Ambion).
|
![]() View larger version (31K): [in a new window] |
FIG. 4. Autophosphorylation and phosphotransfer activities. (A) Vesicle preparations (80 µg) were incubated for 7 min at 30°C with [ -32P]ATP, and then proteins were separated on 10-to-20% Tris-glycine precast Bio-Rad polyacrylamide gels. Lane 1, S. pneumoniae membrane vesicles from vic operon-overproducing strain SOBvicR; lane 2, S. pneumoniae membrane vesicles from strain vicKKO; lane 3, VicK overexpressed as an integral membrane protein in E. coli expression system QIAexpress; lane 4, 18 µg of purified S. pneumoniae HK08 histidine kinase as an MBP; lane 5, heat-treated E. coli overexpressed and autophosphorylated VicK; lane 6, E. coli expression system host strain M15[pREP4] harboring pDSNde without any insert. The strong band visible in lanes 1 and 3 corresponds to autophosphorylated VicK. (B) Autoradiography of a denaturing gel, run to analyze a phosphotransfer experiment. VanS was used as an MBP fusion protein (MBP-VanS). MBP-VanS (18.8 µg) was applied in the experiments shown. Lane 1, phosphotransfer for 5 min from MBP-VanS to VanR (3.7 µg); lane 2, control experiment with [ -32P]ATP autophosphorylated MBP-VanS (with no response regulator added to the reaction mixture). VicR phosphorylation was performed with 18.8 µg of MBP-VanS and decreasing amount of purified VicR protein in lanes 3 (10 µg) and 4 (0.1 µg), respectively. Protein separation was performed on a 10-to-20% Novex precast Tricine gel.
|
Growth behavior of vic operon mutant strains. Attempts to disrupt the vicR gene were carried out as previously described (26, 40), but it was not clear whether this apparently lethal effect was due to vicR inactivation or to polar effects of the disruption on vicK or vicX. Therefore, several mutant strains were constructed in order to assign phenotypes to specific genes within the vic operon. vicK and vicX were successively inactivated by insertion-duplication (8). For this purpose S. pneumoniae was transformed with plasmids carrying a partial copy of the target gene of the histidine kinase (pKOHK2) and the third vic open reading frame (pKOOX2), respectively (Table 2). These findings demonstrate that of the genes in the vic operon only the response regulator gene vicR is essential for in vitro survival. Other mutant strains, expressing the entire operon or portions of it, in approximately 20-fold excess were constructed (Table 1 and Fig. 1). Overexpression was confirmed using Western blot analysis with a polyclonal antibody against VicR (data not shown). The vicK disrupted strain (vicKKO) grew at about 30% of the rate of its parent (R6). Other vic operon mutant strains (promoter-driven knockouts or vicXKO) did not show significantly altered growth rates (Fig. 1).
Competence in vic mutant strains. Natural transformation is affected, directly or indirectly, by two-component systems (2, 18). Therefore, we monitored the relative ease of transformation of vic mutant strains and R6 with replicative plasmid pGK13-KAN (Fig. 1). Most striking was the 400-fold reduction of transformation frequency observed when vicK was inactivated or truncated at its C terminus (vicKst). In order to allow for an artificial effect on transformation due to slow growth phenotype, assays were performed at several time points. Thus, in addition to the standard transformation time window, assays were performed with prolonged incubation in the presence of competence-stimulating peptide (20, 25, 30, and 45 min). Even with these prolonged incubation times, the transformability of the kinase mutants was significantly less than that of the parent strain. A 10-fold difference in transformation frequency was also observed with a mutant strain in which the downstream genes were constitutively activated.
Virulence of vic mutant strains. vic null and overexpression constructs were also used to transform two clinical isolates of serotype 3 and 22 (Table 1). Mutant strains were injected intraperitoneally into groups of five mice. A 1.5-fold increase in mouse survival time could be reproducibly measured for S. pneumoniae mutant strain SOBvicK, indicating decreased virulence (Table 3). The remaining vic operon mutant strains did not show significant changes in virulence behavior in this mouse model.
|
View this table: [in a new window] |
TABLE 3. Phenotypic characteristics of mutant strains used in this studya
|
|
|
|---|
Unusual features of the vic operon proteins. VicK probably responds to intracellular stimuli rather than extracellular environmental signals. In contrast to other histidine kinases, like VanS or ComD, VicK and its closest homologues in Lactococcus lactis and S. pyogenes appear to contain only one transmembrane domain, close to the N terminus. With the cognate response regulator being a cytosolic component, it is very likely that VicK is oriented towards the cytoplasm. Another indication for such a role comes from the N-terminal PAS/PAC core motif of VicK, since bacterial proteins containing PAS domains have been reported to sense oxygen or cytoplasmic redox potentials (43). PAS/PAC domains are involved in protein-protein interactions in response to oxygen or the physiological redox balance of NAD to NADH and FAD to FADH (5, 34). The prototype of such a PAS domain is the photoactive yellow protein from Ectothiorhodospira halophila (16, 32). Homologous domains have been observed in a relatively small number of prokaryotic histidine kinases so far, namely, in Aer, FixL, NifL, KinC, and NtrY systems (45). While the cytosolic domains of most histidine kinases fused to MBP have autophosphorylation activity (43), in vitro activity has been more difficult to demonstrate for histidine kinases containing PAS domains. In vitro autophosphorylation has been shown for an N-terminally truncated form of FixL devoid of its PAS and transmembrane domains (17, 29). However, in the case of VicK, autophosphorylation could be achieved only for the full-length protein incorporated into membrane vesicles. Other truncated VicK constructs, for example, those devoid of its PAS and/or transmembrane domains, did not show this activity. This may reflect the importance of the PAS core domain for full functionality of VicK. Tight control over the activation status of VicR may be deduced from the lack of phosphotransfer from the autophosphorylated VicK to VicR. This is probably because the phosphorylated form of VicR has limited stability in the presence of the histidine kinase.
Since cross-phosphorylation of VicR from VanS can occur, one can envisage that other kinases or even acetyl-phosphate helps to suppress some effects of a vicK kinase disruption, which may also explain how a knockout of the histidine kinase VicK is possible.
VicX, present in vic operon-containing bacteria. The function of the third open reading frame of vicX still remains to be precisely described. VicX has high homology (55% identity) to a B. subtilis open reading frame of unknown function. Close homologues sharing more than 50% identity were also identified in S. pyogenes, S. aureus, and E. faecalis. An analysis using a BLAST search against the Prodom database revealed a domain within VicX showing strong homology (P_Score = 0.002623) (Table 2) with the zinc binding motif HxHxD of a ß-lactamase (accession number, P10425). An inverted repeat sequence followed by a poly(U) downstream of vicX may serve as a rho-independent transcriptional terminator. The first evidence for its possible role may be deduced from the constitutive expression of vicX in strain vicKKOP, where vicK simultaneously was inactivated and the transformation deficiency expected to be caused by vicK inactivation could be partially relieved. As vicX appears to possess a Zn2+ binding motif and the transformability of S. pneumoniae is known to be dependent on Zn2+ (12), VicX may be involved in this effect. However, the Zn2+ binding motif identified in S. pneumoniae VicX is also present in the VicX homologues of other organisms not known to be affected by Zn2+ in the same way. Thus, the potential Zn2+ binding properties of this protein most likely fulfill a more general purpose in influencing one or several enzymes that require Zn2+ as a cofactor. With over 100 such enzymes currently known, a wide variety of potential interaction partners can be envisaged.
Decreased virulence due to imbalance in vic expression. Effects on virulence after mutating the vic operon were observed when the expression of the two vic signaling components were perturbed in strain SOBvicK. Overexpressing the sensor and its downstream gene vicX resulted in a reproducible decrease in virulence. The remaining vic mutant strains did not show altered virulence in our mouse model, which is designed for detecting virulence genes responsible for maintaining an established infection.
Does the vic TCRS integrate several pathways? The role of the vic operon remains uncertain despite the observation of homologues of the vic TCRS in most gram-positive bacteria. The most-striking phenotype described so far implicates the homologous system of B. subtilis in cell division (13), and the wide distribution of vic systems suggests a key role in controlling growth rather than a species-specific signaling function. The severe growth impairment and significant reduction in transformability of VicK kinase mutants of S. pneumoniae strengthen this hypothesis by indicating an important role for this TCRS for growth.
On the basis of the data acquired from the virulence tests, it appears that the Vic proteins maintain a finely tuned balance between signals, rather than constituting a simple on-off switch. Further evidence for an integrative checkpoint comes from the demonstration of cross-phosphorylation of the response regulator. If this occurs in the living cell, it would be possible for several signals to be processed via VicR. On the basis of these observations, the unique features of the vic TCRS and its importance for growth in a number of gram-positive bacteria should help to guide the elucidation of a key regulatory circuit for the growth of gram-positive bacteria.
Present address: Abbott Laboratories, Global Pharmaceutical R&D, Abbott Park, IL 60064-6217. ![]()
Present address: Roche Vitamins AG, Kaiseraugst, Switzerland. ![]()
Present address: Basilea Pharmaceutica Ltd., 4002 Basel, Switzerland. ![]()
|| Present address: Morphochem AG, 4058 Basel, Switzerland. ![]()
|
|
|---|
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»